Journal
CUREUS JOURNAL OF MEDICAL SCIENCE
Volume 15, Issue 1, Pages -Publisher
SPRINGERNATURE
DOI: 10.7759/cureus.34307
Keywords
disseminated intravascular coagulation (dic); soluble interleukin receptors; inflammatory mediators; pancytopenia; hemophagocytic lymphohistiocytosis (hlh); covid 19
Categories
Ask authors/readers for more resources
A case of HLH secondary to dysregulated inflammatory response following COVID-19 is presented, highlighting the challenges in diagnosis and management.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with multiple inflammatory symptoms involving several organ systems, including hematologic manifestations. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome caused by excessive inflammation in the absence of immune regulation. We present the case of a patient with HLH secondary to dysregulated inflammatory response following COVID-19; we also describe the diagnostic and management challenges associated with the condition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
